Atherosclerosis and restenosis: An inflammatory issue

Radiology

Volumn 225, Issue 1, 2002, Pages 10-12

  Smith, Tony P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arteries; Editorial; Femoral; Transluminal angioplasty

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; FIBRINOGEN; SERUM AMYLOID A;

ATHEROSCLEROSIS; CELL INTERACTION; CLINICAL FEATURE; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; HEART CATHETERIZATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

EID: 0036787357     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2251020750     Document Type: Review

References (17)

1. Kalb C. Nobody expected this: repairing Cheney's heart. Newsweek 2000;136:38.
2. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronarystent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331:496-501.
3. Schillinger M, Exner M, Mlekusch W, et al. Vascular inflammation and femoropopliteal PTA: association with restenosis. Radiology 2002; 225:21-26.
4. Ross R. Mechanisms of disease: atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-126.
5. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331:417-424.
6. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99:44-52.
7. Liuzzo G, Buffon A, Biasucci LM, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98:2370-2376.
8. Tashiro H, Shimokawa H, Sadamatsu K, Akoi T, Yamamoto K. Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty. Coron Artery Dis 2001; 12:107-113.
9. Walter DH, Fichtlscherer S, Sellwig M, Auch-Schwelk W, Schachinger V, Zeiher AM. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001; 37:839-846.
10. Montalescot G, Ankri A, Vicaud E, Dobrinski G, Grosgogeat Y, Thomas D. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation 1994; 92:31-38.
11. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999; 100:793-798.
12. Lincoff AM, Kereiakes DJ, Mascelli MA, et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 2001; 104:163-167.
13. Danielsson P, Schatz P, Swartbol P, et al. Response of inflammatory markers to balloon angioplasty in peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg 2000; 20:550-555.
14. Schillinger M, Haumer M, Schlerka G, et al. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation. J Endovasc Ther 2001; 8:477-483.
15. Schillinger M, Exner M, Mlekusch W, et al. Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J Endovasc Ther 2002; 9:59-66.
16. Xiaoshun L, Yanming H, DeScheerder I, et al. Study of Antirestenosis with the Biodivysio Dexamethasone Eluting Stent (STRIDE): a multicenter trial (abstr). J Am Coll Cardiol 2002; 39(suppl A):15A.
17. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimuseluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-1780.